id: risky_alcohol_use_to_cirrhosis
name: Risky Alcohol Use â†’ Cirrhosis
from_node:
  node_id: risky_alcohol_use
  node_name: Risky Alcohol Use
to_node:
  node_id: cirrhosis
  node_name: Cirrhosis
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Risky alcohol consumption in HCV-infected patients accelerates progression
  from early to advanced fibrosis stages'
- 'Step 2: Continued alcohol-related hepatocyte injury and inflammation drive bridging
  fibrosis formation'
- 'Step 3: Progressive architectural distortion and nodule formation occur with sustained
  alcohol exposure'
- 'Step 4: End-stage fibrotic remodeling results in cirrhosis with loss of normal
  liver architecture'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Paul J Clark et al. 2024. "Alcohol does not impact chronic hepatitis
    C treatment outcomes but increases risk for progressive liver disease: Findings
    from a prospective multicentre Australian study (OPERA-C)." *Drug and alcohol
    review*. https://doi.org/10.1111/dar.13914'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.409210'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
